These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 8299548

  • 21. Continuation pharmacotherapy of borderline personality disorder with haloperidol and phenelzine.
    Cornelius JR, Soloff PH, Perel JM, Ulrich RF.
    Am J Psychiatry; 1993 Dec; 150(12):1843-8. PubMed ID: 8238640
    [Abstract] [Full Text] [Related]

  • 22. [Personality disorders in a nonclinical sample of adolescents].
    Chabrol H, Chouicha K, Montovany A, Callahan S, Duconge E, Sztulman H.
    Encephale; 2002 Dec; 28(6 Pt 1):520-4. PubMed ID: 12506264
    [Abstract] [Full Text] [Related]

  • 23. Can mildly depressed outpatients with atypical depression benefit from antidepressants?
    Stewart JW, McGrath PJ, Quitkin FM.
    Am J Psychiatry; 1992 May; 149(5):615-9. PubMed ID: 1575250
    [Abstract] [Full Text] [Related]

  • 24. Course and treatment of atypical depression.
    Nierenberg AA, Alpert JE, Pava J, Rosenbaum JF, Fava M.
    J Clin Psychiatry; 1998 May; 59 Suppl 18():5-9. PubMed ID: 9840192
    [Abstract] [Full Text] [Related]

  • 25. Recognition and diagnosis of atypical depression.
    Thase ME.
    J Clin Psychiatry; 2007 May; 68 Suppl 8():11-6. PubMed ID: 17640153
    [Abstract] [Full Text] [Related]

  • 26. Efficacy of phenelzine and haloperidol in borderline personality disorder.
    Soloff PH, Cornelius J, George A, Nathan S, Perel JM, Ulrich RF.
    Arch Gen Psychiatry; 1993 May; 50(5):377-85. PubMed ID: 8489326
    [Abstract] [Full Text] [Related]

  • 27. [Importance of DSM IV (APA) and ICD-10 (WHO) in diagnosis and treatment of mood disorders].
    Bourgeois M.
    Encephale; 1995 Dec; 21 Spec No 5():47-52. PubMed ID: 8582307
    [Abstract] [Full Text] [Related]

  • 28. Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders.
    Quitkin FM, Stewart JW, McGrath PJ, Liebowitz MR, Harrison WM, Tricamo E, Klein DF, Rabkin JG, Markowitz JS, Wager SG.
    Am J Psychiatry; 1988 Mar; 145(3):306-11. PubMed ID: 3278631
    [Abstract] [Full Text] [Related]

  • 29. Hysteroid dysphoria in depressed inpatients.
    Beeber AR, Kline MD, Pies RW, Manring JM.
    J Clin Psychiatry; 1984 Apr; 45(4):164-6. PubMed ID: 6715288
    [Abstract] [Full Text] [Related]

  • 30. Atypical depression, atypical temperament and a differential antidepressant response to fluoxetine and nortriptyline.
    Joyce PR, Mulder RT, McKenzie JM, Luty SE, Cloninger CR.
    Depress Anxiety; 2004 Apr; 19(3):180-6. PubMed ID: 15129420
    [Abstract] [Full Text] [Related]

  • 31. The assessment and treatment of refractory depression.
    Phillips KA, Nierenberg AA.
    J Clin Psychiatry; 1994 Feb; 55 Suppl():20-6. PubMed ID: 8077165
    [Abstract] [Full Text] [Related]

  • 32. Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studies.
    Chouinard G, Saxena BM, Nair NP, Kutcher SP, Bakish D, Bradwejn J, Kennedy SH, Sharma V, Remick RA, Kukha-Mohamad SA.
    Clin Neuropharmacol; 1993 Feb; 16 Suppl 2():S51-4. PubMed ID: 8313397
    [Abstract] [Full Text] [Related]

  • 33. Management of the depressive component of bipolar disorder.
    Kalin NH.
    Depress Anxiety; 1993 Feb; 4(4):190-8. PubMed ID: 9166651
    [Abstract] [Full Text] [Related]

  • 34. Borderline personality disorder and mood spectrum.
    Berrocal C, Ruiz Moreno MA, Rando MA, Benvenuti A, Cassano GB.
    Psychiatry Res; 2008 Jun 30; 159(3):300-7. PubMed ID: 18445508
    [Abstract] [Full Text] [Related]

  • 35. Irritable-hostile depression: further validation as a bipolar depressive mixed state.
    Benazzi F, Akiskal H.
    J Affect Disord; 2005 Feb 30; 84(2-3):197-207. PubMed ID: 15708417
    [Abstract] [Full Text] [Related]

  • 36. Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depression.
    Quitkin FM, McGrath PJ, Stewart JW, Harrison W, Wager SG, Nunes E, Rabkin JG, Tricamo E, Markowitz J, Klein DF.
    Arch Gen Psychiatry; 1989 Sep 30; 46(9):787-93. PubMed ID: 2673130
    [Abstract] [Full Text] [Related]

  • 37. Can only reversed vegetative symptoms define atypical depression?
    Benazzi F.
    Eur Arch Psychiatry Clin Neurosci; 2002 Dec 30; 252(6):288-93. PubMed ID: 12563537
    [Abstract] [Full Text] [Related]

  • 38. [Drug therapy of patients with emotionally unstable personality].
    Nissen T.
    Tidsskr Nor Laegeforen; 2000 Aug 10; 120(18):2135-41. PubMed ID: 11006733
    [Abstract] [Full Text] [Related]

  • 39. [Personality factors in depressive disorders: contribution of the psychobiologic model developed by Cloninger].
    Pelissolo A, Corruble E.
    Encephale; 2002 Aug 10; 28(4):363-73. PubMed ID: 12232546
    [Abstract] [Full Text] [Related]

  • 40. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors.
    Kennedy SH.
    J Psychiatry Neurosci; 1997 Mar 10; 22(2):127-31. PubMed ID: 9074307
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.